HELX

Franklin Genomic Advancements ETFFranklin Templeton
$33.17-0.16 (-0.48%)Close
AUM$21.7M
Expense Ratio0.50%
NAV$33.36
Holdings63
InceptionFeb 25, 2020

Price Chart

Key Statistics

Previous Close

$33.33

Day Range

$33.17$33.17

52-Week Range

$23.96$38.10

Avg Volume

999

Dividend Yield

0.43%

Expense Ratio

0.50%

AUM

$21.7M

Shares Outstanding

498.0K

Sector Breakdown

SectorWeight %
Healthcare96.77%
Basic Materials2.49%
Technology0.74%

Country Allocation

CountryWeight %
United States84.40%
South Korea3.71%
United Kingdom3.21%
Germany3.00%
Netherlands2.17%
Switzerland1.55%
Other0.97%
Ireland0.72%
Singapore0.27%

Fund Information

Category
Healthcare
Subcategory
Biotech
Inception Date
Feb 25, 2020
Exchange
BATS
Description
The fund seeks capital appreciation by investing in equity securities inside and outside of the United States, including developing or emerging markets. The fund invests in companies that are relevant to its investment theme of genomic advancements that the investment manager believes are substantially focused on/or are expected to substantially benefit from extending and enhancing the quality of human and other life (e.g., animals) by incorporating technological and scientific developments, improvements and advancements in the field of genomics into their business.

Similar ETFs

SymbolNameAUMExpense RatioHoldings
IWMiShares Russell 2000 ETF$70.17B0.19%1,934
XLVState Street Health Care Select Sector SPDR ETF$40.61B0.08%60
VHTVanguard Health Care ETF$19.80B0.09%411
COWZPacer US Cash Cows 100 ETF$18.40B0.49%103
VTWOVanguard Russell 2000 ETF$14.50B0.06%1,969

The Franklin Genomic Advancements ETF (HELX) is an exchange-traded fund issued by Franklin Templeton that launched on Feb 25, 2020. It currently manages $21.7M in assets under management. The fund charges an expense ratio of 0.50%. The fund holds 63 securities in its portfolio. It falls under the Healthcare category.

Top 10 holdings represent 44.2% of the fund

RankSymbolNameWeight %SharesMarket Value
1GHGUARDANT HEALTH INC6.56%15718$1.4M
2NTRANATERA INC6.54%7131$1.4M
3KRYSKRYSTAL BIOTECH INC5.32%4418$1.2M
4BBIOBRIDGEBIO PHARMA INC4.18%12192$906K
5UTHRUNITED THERAPEUTICS CORP4.15%1680$900K
6INSMINSMED INC3.94%5932$853K
7LGNDLIGAND PHARMACEUTICALS3.71%3794$805K
8VRTXVERTEX PHARMACEUTICALS IN3.30%1435$716K
9207940.KSSAMSUNG BIOLOGICS CO LTD3.26%652$706K
10ADPTADAPTIVE BIOTECHNOLOGIES3.23%48245$701K
11AZN.LASTRAZENECA PLC3.23%3589$700K
12MEDPMEDPACE HOLDINGS INC2.86%1327$619K
13LLYELI LILLY & CO2.74%593$594K
14REGNREGENERON PHARMACEUTICALS2.57%722$557K
15EXASEXACT SCIENCES CORP2.51%5269$545K
Page 1 of 2

Detailed Returns

PeriodReturnETFCat. Avgvs Avg
1D
-0.48%
1W
-1.98%
1M
-4.94%
3M
-9.91%
6M
+9.70%
YTD
-8.95%
1Y
+18.11%
3Y
+13.91%
5Y
-25.09%

Moving Averages

20-Day MA

$34.27

Below 20-Day MA
50-Day MA

$35.87

Below 50-Day MA
200-Day MA

$31.88

Above 200-Day MA

Price with Moving Averages

Support & Resistance

52-Week High

$38.10

Current Price

$33.17

52-Week Low

$23.96

$23.96$38.10

Current Yield

0.43%

Annual Dividend

$0.3132

Frequency

1x/year

Last Ex-Date

Dec 30, 2025

Dividend History

Ex-DateAmountPay Date
Dec 30, 2025$0.1433Jan 8, 2026
Dec 30, 2021$0.0039Jan 7, 2022
Dec 13, 2021$0.1141Dec 21, 2021
Dec 14, 2020$0.0518Dec 23, 2020

Dividend Payments Over Time

Category Comparison

MetricHELXHealthcare(223 ETFs)Biotech(39 ETFs)
Fund Info
Expense Ratio0.50%0.60%0.83%
AUM$21.7M$1.25B$1.62B
Dividend Yield0.43%2.75%2.08%
Avg Volume999769.9K1.3M
Holdings6318269
Performance
1-Month Return-5.68%-3.02%-2.29%
6-Month Return+8.39%+5.85%+18.22%
YTD Return-8.52%+0.17%+0.75%
1-Year Return+18.59%+16.65%+28.03%

Compare with Another ETF

Search for an ETF to compare with HELX: